lifesciencesweden.se4d
The key to successful collaboration between industry and academia
Why is collaboration between industry and academia necessary in the life sciences sector? What obstacles exist, and what is ...
lifesciencesweden.se4d
Medicon Valley presents a strong pipeline – highlighting service companies
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...
lifesciencesweden.se1d
Webinar: Support Trial Patients Transitioning to the Commercial Space
Are you a pharmaceutical or biotech manufacturer preparing to commercialize a drug and wondering how to support your Phase ...
lifesciencesweden.se4d
Drug development booms in Medicon Valley
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on ...
lifesciencesweden.se5d
The new Swedish life science strategy – “It will consolidate Sweden as a leader”
The Swedish national life science strategy was launched in December 2019, and it has now been updated with a new government ...
lifesciencesweden.se11d
Advancing Drug Discovery by Combining Complex In-Vitro Models with AI-Powered 3D/4D Image Analysis
- Automation of complex in vitro model generation and quantification at scale - Brightfield and fluorescent imaging ...
lifesciencesweden.se11d
AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is characterised by an increased number of eosinophilic granulocytes in organs and in the bloodstream, ...